Epigenetics Market Size and Growth Rate:

The Global Epigenetics Market Size Will Reach $1,781.5 Million By 2025 From $893.0 Million In 2018 growing At A CAGR Of 14.1% During (2018-2025)

Precision Business Insights (PBI) in its report titled “Global Epigenetics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2018 and Forecast 2019-2025” assesses the market performance over six years forecast period over 2019-2025. The report analyses the market value forecast and provides the strategic insights into the market driving factors, challenges that are hindering the market revenue growth over forecast period.

Browse More Details of the report @ https://www.precisionbusinessinsights.com/market-reports/global-epigenetics-market/

Epigenetics Market Growth Drivers and Restraints:

The global epigenetics market was valued at US$ 893 Mn in 2018 and growing at a CAGR of 5.3% over the forecast period owing to increasing prevalence of tardive dyskinesia, increasing R&D activities, and increasing awareness among the people are driving the growth of the market. Increasing prevalence of various neurological disorders. For instance, In 2017 April, Neurocrine Biosciences has published a report which stated that about 5lakhs people are suffering from TD in U.S. Moreover, growing elderly people coupled with busy and tense life style are anticipated to drive the growth of the marker over the forecast years. However, lack of awareness, delay in diagnosis of disease, and approval of new & alternative treatment for TD are expected to restrain the growth of the market.

Benzodiazepines segment accounted for higher revenue share

Based on drug class, global epigenetics market is segmented Beta blockers, Vitamin E systemic, VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors), Dopaminergic agents, and Benzodiazepines. Benzodiazepines segment accounted for the largest market share in 2018 and is expected to grow with highest CAGR over the forecast period. Beta blockers are expected to grow with highest CAGR over the future years along with the dopaminergic agents.
North America holds leading position in Global Epigenetics Market

PBI’s global epigenetics market report analyses the market in different regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. According to regional analysis, North America is expected to account for larger revenue share in 2018 and the same trend is projected to follow over 2019-2025 owing to increasing activities in the region and support from the government. Moreover, increase in prevalence of tardive dyskinesia, and presence of large number of market players in the region are estimated to drive the growth of the market. Europe and Asia Pacific are anticipated to grow with highest CAGR over the forecast years.
Recent Developments in the Global Epigenetics Market

 In 2017 April, Neurocrine Biosciences received U.S. FDA approval for its INGREZZA (valbenazine) for the treatment of tardive dyskinesia.
 In 2017 August, Teva Pharmaceuticals received U.S. FDA approval for its AUSTEDO for the treatment of tardive dyskinesia in adults

Key player’s profiles in the report are Biogen (U.S), Teva Pharmaceutical Industries Ltd. (Israel), GlaxoSmithKline Plc. (U.K), Johnson & Johnson Services, Inc.(U.S), Pfizer Inc.(U.S), Neurocrine Biosciences, Inc.(U.S), Novartis AG(Switzerland), AstraZeneca (U.K), Bayer AG (Germany) and Sanofi (France).

Avail Sample of the report for more information @ https://www.precisionbusinessinsights.com/request-sample?product_id=17020

Detailed Segmentation of Epigenetics Market:

By Drug Class
o Beta blockers
o Vitamin E systemic
o VMAT2 inhibitors (vesicular monoamine transporter-2 inhibitors)
o Dopaminergic agents
o Benzodiazepines

By Route of Administration
o Oral
o Parenteral

By Distribution Channel
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies

Geography

o North America
o Europe
o Asia-Pacific
o Latin America
o Middle East and Africa (MEA)

About Us:

Precision Business Insights is one of the leading market research and management consulting firm, run by a group of seasoned and highly dynamic market research professionals with a strong zeal to offer high-quality insights.

Contact Us:

Shreya Paul
Senior Business Development Executive
Email @ [email protected]
Call @ +1-866-598-1553
Precision Business Insights